Spa-1 regulates the maintenance and differentiation of human embryonic stem cells

International Journal of Developmental Biology

Volumn 52, Issue 1, 2008, Pages 43-53

  Lee, Young Jin ^a,b   Nah, Hee Young ^a   Hong, Seok Ho ^a   Lee, Ji Won ^a   Jeon, Ilkyung ^a   Jhang, Ho Pak ^c   Huh, Joo Ryung ^a   Kim, Sung Hoon ^a   Chae, Hee Dong ^a   Kang, Byung Moon ^a   Chul, Geun Kim ^b   Kim, Chung Hoon ^a  

^a University of Ulsan   (South Korea)

^b Hanyang University   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

Differentiation; Fate decision; Gene regulation; Signal transduction

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN SPA 1; RAF PROTEIN; RAP1 PROTEIN; REGULATOR PROTEIN; RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VECTORS; GTPASE-ACTIVATING PROTEINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MODELS, BIOLOGICAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 38749138094     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.072274yl     Document Type: Article

References (63)

1. ALAVI, A., HOOD, J.D., FRAUSTO, R. STUPACK, D.G. and CHERESH, D.A. (2003). Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301: 94-96.
2. AMIT, M., SHARIKI, C., MARGULETS, V. and ITSKOVITZ-ELDOR, J. (2004). Feeder layer- and serum-free culture of human embryonic stem cells. Biol. Reprod. 70: 837-845.
3. ARMSTRONG, L., HUGHES, O., YUNG, S., HYSLOP, L., STEWART, R., WAPPLER, I., PETERS, H., WALTER, T., STOJKOVIC, P., EVANS, J., STOJKOVIC, M. and LAKO, M. (2006). The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Genet. 15: 1894-1913.
4. ANDREWS, P.W. (1984). Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103: 285-293.
5. ANDREWS,.PW., BANTING, G., DAMJANOV, I., ARNAUD, D. and AVNER, P. (1984) Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 3: 347-361.
6. BABAIE, Y., HERWIG, R., GREBER, B., BRINK, T.C., WRUCK, W., GROTH, D., LEHRACH, H., BURDON, T., ADJAYE, J. (2007). Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells 25: 500-510.
7. BOS, J.L., DE, ROOIJ. J. and REEDQUIST, K.A. (2001). Rap1 signalling: adhering to new models. Nat. Rev. Mol. Cell. Biol. 2: 369-377.
8. BOYER, L.A., LEE, T.I., COLE, M.F., JOHNSTONE, S.E., LEVINE, S.S., ZUCKER, J.P., GUENTHER, M.G., KUMAR, R.M., MURRAY, H.L, JENNER, R.G., GIFFORD, D.K., MELTON, D.A., JAENISCH, R., YOUNG, R.A. (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956.
9. BURDON, T., CHAMBERS, I., STRACEY, C., NIWA, H. and SMITH, A. (1999). Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs. 165: 131-143.
10. CAREY, K.D., WATSON, R.T., PESSIN, J.E. and STORK, P.J. (2003). The requirement of specific membrane domains for Raf-1 phosphorylation and activation. J. Biol. Chem. 278: 3185-3196.
11. CARON, E. (2003). Cellular functions of the Rap1 GTP-binding protein: a pattern emerges. J. Cell. Sci. 116: 435-440.
12. CHILOECHES, A., MASON, C.S. and MARAIS, R. (2001). S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3. Mol. Cell. Biol. 21: 2423-2434.
13. COOK, S.J., RUBINFELD, B., ALBERT, I. and MCCORMICK, F. (1993). RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12: 3475-3485.
14. DUPUY, A.J., MORGAN, K., VON, LINTIG, F.C., SHEN, H., ACAR, H., HASZ, D.E., JENKINS, N.A., COPELAND, N.G., BOSS, G.R. and LARGAESPADA, D.A. (2001). Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia. J. Biol. Chem. 276: 11804-11811.
15. DVORAK, P., DVORAKOVA, D., KOSKOVA, S., VODINSKA, M., NAJVIRTOVA, M., KREKAC, D. and HAMPL, A. (2005). Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells. Stem Cells 23: 1200-1211.
16. FENDERSON, B.A., ANDREWS, P.W., NUDELMAN, E., CLAUSEN, H. and HAKOMORI, S. (1987). Glycolipid core structure switching from globo- to lacto-and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev. Biol. 122: 21-34.
17. GAO, Q., SRINIVASAN, S., BOYER, S.N., WAZER, D.E. and BAND, V. (1999). The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol. Cell. Biol. 19: 733-744.
18. GAO, Q., SINGH, L., KUMAR, A., SRINIVASAN, S., WAZER, D.E. and BAND, V. (2001) Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells. J. Virol. 75: 4459-4466.
19. GREBER, B., LEHRACH, H., ADJAYE, J. (2007). Fibroblast growth factor 2 modulates transforming growth factor beta signaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC self-renewal. Stem Cells 25: 455-464.
20. HATTORI, M., TSUKAMOTO, N., NUR-E-KAMAL, M.S., RUBINFELD, B., IWAI, K., KUBOTA, H., MARUTA, H. and MINATO, N. (1995). Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression. Mol. Cell. Biol. 15: 552-560.
21. HUMPHREY, R.K., BEATTIE, G.M., LOPEZ, A.D., BUCAY, N., KING, C.C., FIRPO, M.T., ROSE-JOHN, S. and HAYEK, A. (2004) Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 22: 522-530.
22. ISHIDA, D., KOMETANI, K., YANG, H., KAKUGAWA, K., MASUDA, K., IWAI, K., SUZUKI, M., ITOHARA, S., NAKAHATA, T., HIAI, H., KAWAMOTO, H., HATTORI, M. and MINATO, N. (2003). Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice. Cancer Cell 4: 55-65.
23. JAMES, D., LEVINE, A.J., BESSER, D. and HEMMATI-BRIVANLOU, A. (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132: 1273-1282.
24. KOMETANI, K., ISHIDA, D., HATTORI, M. and MINATO, N. (2004). Rap1 and SPA-1 in hematologic malignancy. Trends. Mol. Med. 10: 401-408.
25. KURACHI, H., WADA, Y., TSUKAMOTO, N., MAEDA, M., KUBOTA, H., HATTORI, M., IWAI, K. and MINATO, N. (1997). Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rapl GAP gene product. J. Biol. Chem. 272: 28081-28088.
26. LIVAK, K. J. and SCHMITTGEN, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-[/Delta][/Delta]C(T) ) method. Method 25: 402-408
27. MATSUDA, T., NAKAMURA, T., NAKAO, K., ARAI, T., KATSUKI, M., HEIKE, T. and YOKOTA, T. (1999). STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18: 4261-4269.
28. MERCER, K.E. and PRITCHARD, C.A. (2003). Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta. 1653: 25-40.
29. MITALIPOVA, M., CALHOUN, J., SHIN, S., WININGER, D., SCHULZ, T., NOGGLE, S., VENABLE, A., LYONS, I., ROBINS, A. and STICE, S. (2003). Human embryonic stem cell lines derived from discarded embryos. Stem Cells 21: 521-526.
30. MITSUI, K., TOKUZAWA, Y., ITOH, H., SEGAWA, K., MURAKAMI, M., TAKAHASHI, K., MARUYAMA, M., MAEDA, M. and YAMANAKA, S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
31. MOCHIZUKI, N., OHBA, Y., KIYOKAWA, E., KURATA, T., MURAKAMI, T., OZAKI, T., KITABATAKE, A., NAGASHIMA, K., MATSUDA, M. (1999). Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha. Nature 400:891-894
32. MORRISON, T.B., WEIS, J.J. and WITTWER, C.T. (1998). Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24: 954-958.
33. NIWA, H., BURDON, T., CHAMBERS, I. and SMITH, A. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes. Dev. 12: 2048-2060.
34. NIWA, H. (2001). Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct. Funct. 26: 137-148.
35. O'NEILL, E. and KOLCH, W. (2004). Conferring specificity on the ubiquitous Raf/MEK signalling pathway. Br. J. Cancer 90: 283-288.
36. PAK, D.T., YANG, S., RUDOLPH-CORREIA, S., KIM, E. and SHENG, M. (2001). Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron 31: 289-303.
37. PAPAIOANNOU, V.E., WATERS, B.K. and ROSSANT, J. (1984). Interactions between diploid embryonal carcinoma cells and early embryonic cells. Cell Differ. 15: 175-179.
38. PARK, J.H., KIM, S.J., OH, E.J., MOON, S.Y., ROH, S.I., KIM, C.G. and YOON, H.S. (2003). Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biol. Reprod. 69: 2007-2014.
39. PEASE, S., BRAGHETTA, P., GEARING, D., GRAIL, D. and WILLIAMS, R.L. (1990). Isolation of embryonic stem (ES) cells in media supplemented with recombinant leukemia inhibitory factor (LIF). Dev. Biol. 141: 344-352.
40. PROWSE, A.B., MCQUADE, L.R., BRYANT, K.J., VAN, DYK, D.D., TUCH, B.E. and GRAY, P.P. (2005). A proteome analysis of conditioned media from human neonatal fibroblasts used in the maintenance of human embryonic stem cells. Proteomics 5: 978-989.
41. RAO, R.R., CALHOUN, J.D., QIN, X., REKA, Y.A.R., CLARK, J.K. and STICE, S.L. (2004). Comparative transcriptional profiling of two human embryonic stem cell lines. Biotechnol. Bioeng. 88: 273-286.
42. REUBINOFF, B.E., PERA, M.F., FONG, C.Y., TROUNSON, A. and BONGSO, A. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18: 399-404.
43. ROSSANT, J. and PAPAIOANNOU, V.E. (1984). The relationship between embryonic, embryonal carcinoma and embryo-derived stem cells. Cell Differ. 15: 155-161.
44. ROUSSEAU-MERCK, M.F., PIZON, V., TAVITIAN, A. and BERGER, R. (1990). Chromosome mapping of the human RAS-related RAP1A, RAP1B, and RAP2 genes to chromosomes 1p12, p13, 12q14, and 13q34, respectively. Cytogenet. Cell Genet. 53: 2-4.
45. ROY, S., MCPHERSON, R.A., APOLLONI, A., YAN, J., LANE, A., CLYDE-SMITH, J. and HANCOCK, J.F. (1998). 14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo. Mol. Cell. Biol. 18: 3947-3955.
46. ROY, B.C., KOHU, K., MATSUURA, K., YANAI, H. and AKIYAMA, T. (2002). SPAL, a Rap-specific GTPase activating protein, is present in the NMDA receptor-PSD-95 complex in the hippocampus. Genes Cells 7: 607-617.
47. SATO, N., MEIJER, L., SKALTSOUNIS, L., GREENGARD, P. and BRIVANLOU, A.H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10: 55-63.
48. SCHMITT, J.M. and STORK, P.J. (2001). Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1. Mol. Cell. Biol. 21: 3671-3683.
49. SCHURINGA, J.J., VAN, DER, SCHAAF, S., VELLENGA, E., EGGEN, B.J. and KRUIJER, W. (2002). LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells. Exp. Cell. Res. 274: 119-129.
50. SHAMBLOTT, M.J., AXELMAN, J., WANG, S., BUGG, E.M., LITTLEFIELD, J.W., DONOVAN, P.J., BLUMENTHAL, P.D., HUGGINS, G.R. and GEARHART, J.D. (1998). Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA 95: 13726-13731.
51. SOLTER, D. and KNOWLES, B.B. (1975). Immunosurgery of mouse blastocyst. Proc. Natl. Acad. Sci. USA 72: 5099-5102.
52. STORK, P.J. (2003). Does Rap1 deserves a bad Rap? Trends. Biochem. Sci. 28: 267-275.
53. THOMSON, J.A., ITSKOVITZ-ELDOR, J., SHAPIRO, S.S., WAKNITZ, M.A., SWIERGIEL, J.J., MARSHALL, V.S. and JONES, J.M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
54. THOMSON, J.A. and ODORICO, J.S. (2000). Human embryonic stem cell and embryonic germ cell lines. Trends. Biotechnol. 18: 53-57.
55. VOSSLER, M.R., YAO, H., YORK, R.D., PAN, M.G., RIM, C.S. and STORK, P.J. (1997). cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89: 73-82.
56. WADA, Y., KUBOTA, H., MAEDA, M., TANIWAKI, M., HATTORI, M., IMAMURA, S., IWAI, K. and MINATO, N. (1997). Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human. Genomics 39: 66-73.
57. WALSH, J. and ANDREWS, P.W. (2003). Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell. Apmis 111: 197-210.
58. WONG, K.F. (1999). 11q13 is a cytogenetically promiscuous site in hematologic malignancies. Cancer Genet. Cytogenet. 113: 93-95.
59. YAJNIK, V., PAULDING, C., SORDELLA, R., MCCLATCHEY, A.I., SAITO, M., WAHRER, D.C., REYNOLDS, P., BELL, D.W., LAKE, R., VAN, DEN, HEUVEL, S., SETTLEMAN, J. and HABER, D.A. (2003). DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell 112: 673-684.
60. YANG, Y.H., DUDOIT, S., LUU, P., LIN, D.M., PENG, V., NAGI, J. and SPEED, T.P. (2002). Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucl. Acid. Res. 30: e15
61. YING, Q.L., NICHOLS, J., CHAMBERS, I. and SMITH, A. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292.
62. YOSHIDA, K., CHAMBERS, I., NICHOLS, J., SMITH, A., SAITO, M., YASUKAWA, K., SHOYAB, M., TAGA, T. and KISHIMOTO, T. (1994). Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech. Dev. 45: 163-171.
63. ZHANG, B.H. and GUAN, K.L. (2000). Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO. J. 19: 5429-5439.